Veru Inc. logo

Veru Inc.

NASDAQ:VERU

Overview | Financials
Company Name Veru Inc.
Symbol VERU
Currency USD
Price 0.676
Market Cap 98,926,307
Dividend Yield 0%
52-week-range 0.36 - 1.92
Industry Biotechnology
Sector Healthcare
CEO Dr. Mitchell S. Steiner F.A.C.S, F.A.C.S., M.D.
Website https://www.verupharma.com

An error occurred while fetching data.

About Veru Inc.

Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial

Related Stocks

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

51.85 USD

MannKind Corporation logo

MannKind Corporation

MNKD

6.82 USD

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

0.65 USD

NeoGenomics, Inc. logo

NeoGenomics, Inc.

NEO

16.83 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

92.84 USD

Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

SAVA

2.5 USD

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

86.7 USD

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.49 USD

Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc.

ARQT

14.3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD